Client: Unbranded Jazz Pharma
Agency: Area 23
Year: 2023
SVP / GCD

California-based Jazz Pharma challenged us to create an unbranded campaign that was as bold and forward-thinking as their next-generation HER2-directed therapy for GEA. The brief carried real weight: translate the science, the hope, and the urgency behind a breakthrough treatment into a narrative that could genuinely move people. Our goal was to capture not just the innovation behind the therapy, but the profound impact it could have on patients waiting for something new.

Awards
3x Silver New York Festivals 2024
1x Bronze Clio Health 2024
1x Bronze AdAge
1x Silver MM+M Awards
1x Shortlist Cannes Lions 2024
1x Shortlist D&AD 2024
3x The Creative Floor Healthcare Awards